Menu

Blog Posts

News Alert

Stakeholders React to HELP Committee Chair Cassidy’s 340B Probe Findings, Reform Recommendations

Shannon Young, Associate Editor/Senior Writer Views
340B stakeholders offered mixed responses to the findings of U.S. Sen. Bill Cassidy's (R-La.) investigation into the 340B program.
340B hospitals, contract pharmacies, health center advocates and the drug industry offered mixed responses Thursday on the long-awaited findings and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Breaking News

Senate HELP Committee Chair Cassidy Calls for Federal 340B Reforms, Releases Findings of Yearslong Congressional Probe

Shannon Young, Associate Editor/Senior Writer Views
U.S. Sen. Bill Cassidy (R-La.) laid out a series of potential policies Congress could adopt to “bring much-needed reform to the 340B program” in a 195-page report, which summarized the findings of the investigation he launched in 2023—as the HELP panel’s top Republican—into how certain hospitals, health centers, chain pharmacies and drugmakers operate their 340B programs.
The leader of a key U.S. Senate Committee tasked with overseeing the 340B program called Thursday for Congress to improve [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Lobbying Remained Strong in Early 2025, Filings Show

Shannon Young, Associate Editor/Senior Writer Views
Just over 300 firms listed the 340B program in their first quarter lobbying disclosure forms that were due April 21.
While much of the focus in Washington, D.C. has been on confirmation hearings and budget matters, the 340B program continued [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Indiana Legislature Passes Sweeping 340B Hospital Reporting Bill, Sends to Gov. Braun

William Newton, Associate Editor/Senior Writer Views
Both chambers of the Indiana legislature on April 23 passed a 340B hospital reporting bill.
Indiana lawmakers yesterday overwhelmingly approved a bill that would require state hospitals to annually report extensive financial and operational information [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

State Contract Pharmacy Lawsuit Roundup: Appellate Court Briefings on 340B Laws in West Virginia, Louisiana

William Newton and Shannon Young, Associate Editor/Senior Writer Views
Key briefs were filed recently in state contract pharmacy litigation in two federal appeals court.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

As Trump Pharmaceutical Tariffs Loom, Drug Industry Pledges Investment in U.S. Manufacturing, Warns of Disruptions 

Bella Czajkowski, National Correspondent Views
A recent survey of biotechnology firms reported that Trump's planned pharmaceutical tariffs would set back scientific innovation and reduce patients' access to medications.
The drug industry is bracing for the Trump administration’s planned tariffs on pharmaceutical products and ingredients, warning of supply chain [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

RxParadigm

Q: Tell us some interesting details about your company’s history.

RxParadigm, founded by industry veteran Mesfin Tegenu, is dedicated to developing technology solutions that streamline the drug supply chain and

…
Read More »

Health System CEOs Meet with RFK Jr. and Encourage Him to Preserve and Strengthen 340B at HHS Roundtable 

Shannon Young, Associate Editor/Senior Writer Views
The CEOs of Cincinnati’s Bon Secours Mercy Health, Cleveland-based University Hospitals, Kansas-based HaysMed and Minnesota’s Riverwood Healthcare Center met with HHS Secretary Robert F. Kennedy Jr. last week. (Photo courtesy: Kennedy's X post.)
The leaders of four health systems recently met with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

HHS Continues to Oppose Unapproved Drugmaker 340B Rebate Models in New Legal Filings

William Newton, Associate Editor/Senior Writer Views
HHS has again urged a federal district court to reject multiple drug industry lawsuits seeking to implement 340B rebate models.
The U.S. Department of Health and Human Services (HHS) is continuing its pushback against drugmaker attempts to unilaterally convert upfront [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Industry Insights Logo

Should We Prepare for a 340B Rebate Model?

Sponsored Content Views
How to assess if a rebate model will occur and how to get prepared

SPONSORED CONTENT

As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to operate their 340B programs.  This may include conducting an annual independent audit, financially reconciling the previous fiscal year, getting

…
Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live